company background image
A038070 logo

Seoulin BioscienceLtd KOSDAQ:A038070 Stock Report

Last Price

₩7.23k

Market Cap

₩62.5b

7D

-1.1%

1Y

-21.4%

Updated

26 Dec, 2024

Data

Company Financials

Seoulin Bioscience Co.,Ltd.

KOSDAQ:A038070 Stock Report

Market Cap: ₩62.5b

A038070 Stock Overview

A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. More details

A038070 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Seoulin Bioscience Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Seoulin BioscienceLtd
Historical stock prices
Current Share Price₩7,230.00
52 Week High₩12,240.00
52 Week Low₩6,130.00
Beta0.73
1 Month Change11.75%
3 Month Change-5.98%
1 Year Change-21.41%
3 Year Change-64.48%
5 Year Change-7.90%
Change since IPO-14.03%

Recent News & Updates

Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Low P/S No Reason For Excitement

Dec 04
Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Low P/S No Reason For Excitement

Recent updates

Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Low P/S No Reason For Excitement

Dec 04
Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Low P/S No Reason For Excitement

Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why

May 03
Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why

Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 13
Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year

Feb 15
Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year

Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?

Jan 20
Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?

Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Dec 25
Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Dec 06
Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Shareholder Returns

A038070KR BiotechsKR Market
7D-1.1%-2.3%-1.9%
1Y-21.4%14.9%-9.5%

Return vs Industry: A038070 underperformed the KR Biotechs industry which returned 16.3% over the past year.

Return vs Market: A038070 underperformed the KR Market which returned -9% over the past year.

Price Volatility

Is A038070's price volatile compared to industry and market?
A038070 volatility
A038070 Average Weekly Movement12.6%
Biotechs Industry Average Movement8.8%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.8%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A038070's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A038070's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1984104Eul-Moon Hwangwww.seoulin.co.kr

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd.

Seoulin Bioscience Co.,Ltd. Fundamentals Summary

How do Seoulin BioscienceLtd's earnings and revenue compare to its market cap?
A038070 fundamental statistics
Market cap₩62.52b
Earnings (TTM)-₩661.53m
Revenue (TTM)₩82.09b

0.8x

P/S Ratio

-93.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A038070 income statement (TTM)
Revenue₩82.09b
Cost of Revenue₩64.14b
Gross Profit₩17.95b
Other Expenses₩18.61b
Earnings-₩661.53m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-77.35
Gross Margin21.87%
Net Profit Margin-0.81%
Debt/Equity Ratio1.7%

How did A038070 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

-126%

Payout Ratio

Does A038070 pay a reliable dividends?

See A038070 dividend history and benchmarks
When do you need to buy A038070 by to receive an upcoming dividend?
Seoulin BioscienceLtd dividend dates
Ex Dividend DateDec 27 2024
Dividend Pay DateApr 28 2025
Days until Ex dividend1 day
Days until Dividend pay date123 days

Does A038070 pay a reliable dividends?

See A038070 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:27
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Seoulin Bioscience Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sung Hwan ChoiKyobo Securities Co., Ltd
Ju-Hong ChoeLS Securities Co., Ltd.
Seung KimSK Securities Co., Ltd.